Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lord, Christopher J.
Garrett, Michelle D.
and
Ashworth, Alan
2006.
Targeting the Double-Strand DNA Break Repair Pathway as a Therapeutic Strategy.
Clinical Cancer Research,
Vol. 12,
Issue. 15,
p.
4463.
Plummer, Ruth
2006.
Poly(ADP-ribose) polymerase inhibition and its potential use in malignant melanoma.
Expert Review of Dermatology,
Vol. 1,
Issue. 4,
p.
599.
Gagné, Jean-Philippe
Hendzel, Michael J
Droit, Arnaud
and
Poirier, Guy G
2006.
The expanding role of poly(ADP-ribose) metabolism: current challenges and new perspectives.
Current Opinion in Cell Biology,
Vol. 18,
Issue. 2,
p.
145.
Granfors, Torvald
Modig, Hans
Damber, Jan-Erik
and
Tomic, Radisa
2006.
Long-Term Followup of a Randomized Study of Locally Advanced Prostate Cancer Treated With Combined Orchiectomy and External Radiotherapy Versus Radiotherapy Alone.
Journal of Urology,
Vol. 176,
Issue. 2,
p.
544.
Cockcroft, Xiao-ling
Dillon, Krystyna J.
Dixon, Lesley
Drzewiecki, Jan
Kerrigan, Frank
Loh, Vincent M.
Martin, Niall M.B.
Menear, Keith A.
and
Smith, Graeme C.M.
2006.
Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymerase.
Bioorganic & Medicinal Chemistry Letters,
Vol. 16,
Issue. 4,
p.
1040.
Schreiber, Valérie
Dantzer, Françoise
Ame, Jean-Christophe
and
de Murcia, Gilbert
2006.
Poly(ADP-ribose): novel functions for an old molecule.
Nature Reviews Molecular Cell Biology,
Vol. 7,
Issue. 7,
p.
517.
Kunzmann, Andrea
Liu, Dan
Annett, Kathryn
Malaisé, Muriel
Thaa, Bastian
Hyland, Paul
Barnett, Yvonne
and
Bürkle, Alexander
2006.
Flow-cytometric assessment of cellular poly(ADP-ribosyl)ation capacity in peripheral blood lymphocytes.
Immunity & Ageing,
Vol. 3,
Issue. 1,
Thomas, Huw D.
Calabrese, Christopher R.
Batey, Michael A.
Canan, Stacie
Hostomsky, Zdenek
Kyle, Suzanne
Maegley, Karen A.
Newell, David R.
Skalitzky, Donald
Wang, Lan-Zhen
Webber, Stephen E.
and
Curtin, Nicola J.
2007.
Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.
Molecular Cancer Therapeutics,
Vol. 6,
Issue. 3,
p.
945.
Sánchez-Fidalgo, Susana
Villegas, Isabel
Martín, Antonio
Sánchez-Hidalgo, Marina
and
Alarcón de la Lastra, Catalina
2007.
PARP inhibition reduces acute colonic inflammation in rats.
European Journal of Pharmacology,
Vol. 563,
Issue. 1-3,
p.
216.
Miknyoczki, Sheila
Chang, Hong
Grobelny, Jennifer
Pritchard, Sonya
Worrell, Candace
McGann, Natalie
Ator, Mark
Husten, Jean
Deibold, James
Hudkins, Robert
Zulli, Allison
Parchment, Ralph
and
Ruggeri, Bruce
2007.
The selective poly(ADP-ribose) polymerase-1(2) inhibitor, CEP-8983, increases the sensitivity of chemoresistant tumor cells to temozolomide and irinotecan but does not potentiate myelotoxicity.
Molecular Cancer Therapeutics,
Vol. 6,
Issue. 8,
p.
2290.
Donawho, Cherrie K.
Luo, Yan
Luo, Yanping
Penning, Thomas D.
Bauch, Joy L.
Bouska, Jennifer J.
Bontcheva-Diaz, Velitchka D.
Cox, Bryan F.
DeWeese, Theodore L.
Dillehay, Larry E.
Ferguson, Debra C.
Ghoreishi-Haack, Nayereh S.
Grimm, David R.
Guan, Ran
Han, Edward K.
Holley-Shanks, Rhonda R.
Hristov, Boris
Idler, Kenneth B.
Jarvis, Ken
Johnson, Eric F.
Kleinberg, Lawrence R.
Klinghofer, Vered
Lasko, Loren M.
Liu, Xuesong
Marsh, Kennan C.
McGonigal, Thomas P.
Meulbroek, Jonathan A.
Olson, Amanda M.
Palma, Joann P.
Rodriguez, Luis E.
Shi, Yan
Stavropoulos, Jason A.
Tsurutani, Alan C.
Zhu, Gui-Dong
Rosenberg, Saul H.
Giranda, Vincent L.
and
Frost, David J.
2007.
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models.
Clinical Cancer Research,
Vol. 13,
Issue. 9,
p.
2728.
O'Connor, M J
Martin, N M B
and
Smith, G C M
2007.
Targeted cancer therapies based on the inhibition of DNA strand break repair.
Oncogene,
Vol. 26,
Issue. 56,
p.
7816.
Dunn, Derek
Husten, Jean
Ator, Mark A.
and
Chatterjee, Sankar
2007.
Novel poly(ADP-ribose) polymerase-1 inhibitors.
Bioorganic & Medicinal Chemistry Letters,
Vol. 17,
Issue. 2,
p.
542.
Gao, Hong
Coyle, Donna L.
Meyer-Ficca, Mirella L.
Meyer, Ralph G.
Jacobson, Elaine L.
Wang, Zhao-Qi
and
Jacobson, Myron K.
2007.
Altered poly(ADP-ribose) metabolism impairs cellular responses to genotoxic stress in a hypomorphic mutant of poly(ADP-ribose) glycohydrolase.
Experimental Cell Research,
Vol. 313,
Issue. 5,
p.
984.
Meyer, Ralph G.
Meyer-Ficca, Mirella L.
Whatcott, Clifford J.
Jacobson, Elaine L.
and
Jacobson, Myron K.
2007.
Two small enzyme isoforms mediate mammalian mitochondrial poly(ADP-ribose) glycohydrolase (PARG) activity.
Experimental Cell Research,
Vol. 313,
Issue. 13,
p.
2920.
Curtin, Nicola
2007.
Therapeutic potential of drugs to modulate DNA repair in cancer.
Expert Opinion on Therapeutic Targets,
Vol. 11,
Issue. 6,
p.
783.
Peralta-Leal, Andreína
Rodríguez, María Isabel
and
Oliver, Francisco Javier
2008.
Poly(ADP-ribose)polymerase-1 (PARP-1) in carcinogenesis: potential role of PARP inhibitors in cancer treatment.
Clinical and Translational Oncology,
Vol. 10,
Issue. 6,
p.
318.
Brain, John G.
Rostron, Anthony J.
Dark, John H.
and
Kirby, John A.
2008.
Activation and Modulation of Cardiac Poly-Adenosine Diphosphate Ribose Polymerase Activity in a Rat Model of Brain Death.
Transplantation,
Vol. 85,
Issue. 9,
p.
1348.
Mikhailov, Sergey N.
Kulikova, Irina V.
Nauwelaerts, Koen
and
Herdewijn, Piet
2008.
Synthesis of 2′-O-α-d-ribofuranosyladenosine, monomeric unit of poly(ADP–ribose).
Tetrahedron,
Vol. 64,
Issue. 12,
p.
2871.
Plummer, Ruth
Jones, Christopher
Middleton, Mark
Wilson, Richard
Evans, Jeffrey
Olsen, Anna
Curtin, Nicola
Boddy, Alan
McHugh, Peter
Newell, David
Harris, Adrian
Johnson, Patrick
Steinfeldt, Heidi
Dewji, Raz
Wang, Diane
Robson, Lesley
and
Calvert, Hilary
2008.
Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors.
Clinical Cancer Research,
Vol. 14,
Issue. 23,
p.
7917.